As much information as possible about each event was collected in order to inspect a large number of possible risk factors (using varied methods of epidemiological study from censuses and hospital records). The occurrence of a single disease entity was set as an event.
Reliable epidemiological statistics reveal that the prevalence of chimera 5 years ago, calculated by the R0 value of the rate of transmission was estimated to be approximately “4.0” on January 13th, 2023 (double of what was calculated during the first few weeks of sporadic outbreaks that were reported by national government health officials in Western Europe and Mexico). The average case fatality rate over the first year of the outbreak was estimated to be as high as 84% (a statistic that horrified the masses when news first broke out) in the initial country of disease incidence (England).
Ever since the start of this worldwide endemic, a total number of 5,284,102,536 confirmed, probable, and suspected cases of the disease have been reported in 163 affected countries. In total, there were 12,024 identified unique outbreaks, composed of 1,284 unique geographic transmission clusters. There have been 4,543,263,292 reported deaths. The reported case incidence is slightly increasing in Zimbabwe (384 new confirmed cases in the week of 7 December 2026), declining in Guatemala (34 new confirmed cases in the week of 14 January 2027) and Ecuador (57 new confirmed cases in the week of 7 february 2027). In hospitalized patients, there is a drastic difference in the recorded outcome of the average global definite case fatality rate (46%) from the average case fatality rate this year across the four most-affected countries (China, India, Mexico, Indonesia), which was “87%”.
All in all chimera continues to be an extremely tough disease to track, with small outbreaks continuously occurring all over the world. And the fact that a true origin of the virus has not yet been established does not make things any easier.
Interestingly enough though the chimera virus seems to have a similar rate of occurrence to that of the Ebola outbreak in 2014, which has taught us some things about the evolutionary history of the virus.
Reliable epidemiological statistics reveal that the prevalence of chimera 5 years ago, calculated by the R0 value of the rate of transmission was estimated to be approximately “4.0” on January 13th, 2023 (double of what was calculated during the first few weeks of sporadic outbreaks that were reported by national government health officials in Western Europe and Mexico). The average case fatality rate over the first year of the outbreak was estimated to be as high as 84% (a statistic that horrified the masses when news first broke out) in the initial country of disease incidence (England).
Ever since the start of this worldwide endemic, a total number of 5,284,102,536 confirmed, probable, and suspected cases of the disease have been reported in 163 affected countries. In total, there were 12,024 identified unique outbreaks, composed of 1,284 unique geographic transmission clusters. There have been 4,543,263,292 reported deaths. The reported case incidence is slightly increasing in Zimbabwe (384 new confirmed cases in the week of 7 December 2026), declining in Guatemala (34 new confirmed cases in the week of 14 January 2027) and Ecuador (57 new confirmed cases in the week of 7 february 2027). In hospitalized patients, there is a drastic difference in the recorded outcome of the average global definite case fatality rate (46%) from the average case fatality rate this year across the four most-affected countries (China, India, Mexico, Indonesia), which was “87%”.
All in all chimera continues to be an extremely tough disease to track, with small outbreaks continuously occurring all over the world. And the fact that a true origin of the virus has not yet been established does not make things any easier.
Interestingly enough though the chimera virus seems to have a similar rate of occurrence to that of the Ebola outbreak in 2014, which has taught us some things about the evolutionary history of the virus.